Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-29
2011-03-29
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S248000, C514S252030, C514S252050, C514S256000, C514S318000, C514S403000, C544S235000, C544S242000, C544S333000, C544S405000, C546S208000, C546S210000, C546S268100, C546S268400, C546S275400
Reexamination Certificate
active
07915250
ABSTRACT:
Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.
REFERENCES:
patent: 4510139 (1985-04-01), Bailey
patent: 6048885 (2000-04-01), Takase et al.
patent: 6960614 (2005-11-01), Barrett et al.
patent: 6974878 (2005-12-01), Guram et al.
patent: 7141312 (2006-11-01), Richter et al.
patent: 7371751 (2008-05-01), Nettekoven et al.
patent: 2004/0116710 (2004-06-01), Wallace et al.
patent: 2004/0192653 (2004-09-01), Munson et al.
patent: 2005/0049276 (2005-03-01), Kaufman
patent: 2005/0049419 (2005-03-01), Wallace et al.
patent: 2005/0054701 (2005-03-01), Wallace et al.
patent: 2005/0153962 (2005-07-01), Nettekoven et al.
patent: 2005/0256123 (2005-11-01), Marlow et al.
patent: 2006/0030610 (2006-02-01), Koch et al.
patent: 2007/0105859 (2007-05-01), Isshiki et al.
patent: 1 262 176 (2002-12-01), None
patent: 1 780 197 (2007-05-01), None
patent: 2003-192592 (2003-07-01), None
patent: 2005-162727 (2005-06-01), None
patent: 89/03818 (1989-05-01), None
patent: 97/12613 (1997-04-01), None
patent: 98/37881 (1998-09-01), None
patent: 99/01421 (1999-01-01), None
patent: 99/01426 (1999-01-01), None
patent: 00/35435 (2000-06-01), None
patent: 00/35436 (2000-06-01), None
patent: 00/37141 (2000-06-01), None
patent: 00/40235 (2000-07-01), None
patent: 00/40237 (2000-07-01), None
patent: 00/41505 (2000-07-01), None
patent: 00/41994 (2000-07-01), None
patent: 00/42003 (2000-07-01), None
patent: 00/42022 (2000-07-01), None
patent: 00/42029 (2000-07-01), None
patent: 01/05390 (2001-01-01), None
patent: 01/05391 (2001-01-01), None
patent: 01/05392 (2001-01-01), None
patent: 01/05393 (2001-01-01), None
patent: 01/19788 (2001-03-01), None
patent: 01/68619 (2001-09-01), None
patent: 01/77101 (2001-10-01), None
patent: 02/06213 (2002-01-01), None
patent: 03/037329 (2003-05-01), None
patent: 03/062189 (2003-07-01), None
patent: 03/062191 (2003-07-01), None
patent: 03/077855 (2003-09-01), None
patent: 03/077914 (2003-09-01), None
patent: 03/103590 (2003-12-01), None
patent: 2004/056789 (2004-07-01), None
patent: 2004/083167 (2004-09-01), None
patent: 2004/089876 (2004-10-01), None
patent: 2004/113347 (2004-12-01), None
patent: 2005/000818 (2005-01-01), None
patent: 2005/007616 (2005-01-01), None
patent: 2005/009975 (2005-02-01), None
patent: 2005/023251 (2005-03-01), None
patent: 2005/023759 (2005-03-01), None
patent: 2005/051300 (2005-06-01), None
patent: 2005/051301 (2005-06-01), None
patent: 2005/051302 (2005-06-01), None
patent: 2006/010594 (2006-02-01), None
patent: 2006/045514 (2006-05-01), None
Shpiro, N. et al., “Improved Experimental Procedure for the Synthesis of the Potent MEK Inhibitor PD184352”, Synthetic Communications, vol. 35, 2005-2265-2269.
Aay Naing
Anand Neel Kumar
Blazey Charles M.
Bowles Owen Joseph
Bussenius Joerg
Anderson Rebecca L
Exelixis Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
Shterengarts Samantha L
LandOfFree
Azetidines as MEK inhibitors for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azetidines as MEK inhibitors for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azetidines as MEK inhibitors for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2697512